Fifteen months after starting the job, Andrew von Eschenbach finally has the title: the former director of the National Cancer Institute was confirmed by the Senate as the twentieth commissioner of the Food & Drug Administration on December 7. He was sworn in December 13.
The swearing-in was anti-climactic at best. Von Eschenbach took over as FDA commissioner in September 2005, stepping in to calm...




